跳至主要内容
临床试验/ISRCTN35169306
ISRCTN35169306已完成不适用

The effect of multi-level botulinum toxin treatment and intensive rehabilitation on walking ability in children with cerebral palsy

Vrije University Medical Centre (VUMC) (The Netherlands)0 个研究点目标入组 47 人开始时间: 2005年8月4日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
47

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Diagnosis of cerebral palsy (CP), hemiplegia or diplegia
  • 2. Ability to walk with or without a walking aid, with or without an ankle-foot orthosis
  • 2. Gait characterised by persistent flexion of the hip and knee in mid-stance when walking
  • 3. Aged between 4 and 12 years

排除标准

  • 1. BTX treatment in lower extremities 16 weeks before inclusion
  • 2. Orthopaedic surgery 24 weeks before inclusion
  • 3. Contra-indication for BTX-A
  • 4. Contra-indication for general anaesthesia
  • 5. Severe fixed contractures
  • 6. Orthopaedic deformities, which have a bad influence on walking:
  • 6.1. (Sub)luxation of the hip with a migration index greater than 50 degrees
  • 6.2. Hip endorotation contracture greater than 15 degrees
  • 6.3. Flexion contracture of knee greater than 15 degrees
  • 7. Presence of ataxia of dyskinesia
  • 8. Other problems which have a negative influence on walking

研究者

发起方
Vrije University Medical Centre (VUMC) (The Netherlands)

相似试验